Epidemiology of COVID-19 scenario in India

Q3 Agricultural and Biological Sciences Novel Research in Microbiology Journal Pub Date : 2021-08-01 DOI:10.21608/nrmj.2021.190244
Prasanta Majumder, Shyamalendu Laskar, Aesha Zafna, M. Koul, Anudarsh P. Kalakumari, Pallavi A. Thomas
{"title":"Epidemiology of COVID-19 scenario in India","authors":"Prasanta Majumder, Shyamalendu Laskar, Aesha Zafna, M. Koul, Anudarsh P. Kalakumari, Pallavi A. Thomas","doi":"10.21608/nrmj.2021.190244","DOIUrl":null,"url":null,"abstract":"There was an outbreak of a new Coronavirus infection in Wuhan, Hubei Province, China in late December 2019, which caused acute respiratory syndrome of unknown etiology. The World Health Organization (WHO) named the viral causal agent as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV2) or COVID-19, and declared this infection as a pandemic on the 11 th of March, 2020. The first case of COVID-19 infection in India was reported on late January, 2020, and since then the numbers of confirmed cases have been increasing; thus the government had announced total lockdown of all activities. Most people infected with the COVID-19 virus experience mild to moderate respiratory illness, and recover without the need for special treatments. The elderly people and those with medical problems such as; cardiovascular disease, diabetes, chronic respiratory disease and cancer; are more likely to develop severe illness. Globally, corona virus cases rose to more than 500,000 for the first time on the 27 th of October, 2020. Within two weeks and since 30 th of October, 2020, COVID-19 cases had risen by almost 25 %, and about 400,000 daily cases were reported worldwide. The United States (US) was leading the global corona virus crisis with 8.9 million recorded infections and nearly 228,000 deaths worldwide. Asia had surpassed 10 million infections of the new corona virus on the 31 of October, 2020, and India reported an average of 48,000 cases daily with a total of 8 million cases. The aim of this review was to explore the epidemiological prevalence of COVID-19 in India along with age and gender stratified prevalence of this viral infection.","PeriodicalId":34593,"journal":{"name":"Novel Research in Microbiology Journal","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Novel Research in Microbiology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/nrmj.2021.190244","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Agricultural and Biological Sciences","Score":null,"Total":0}
引用次数: 0

Abstract

There was an outbreak of a new Coronavirus infection in Wuhan, Hubei Province, China in late December 2019, which caused acute respiratory syndrome of unknown etiology. The World Health Organization (WHO) named the viral causal agent as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV2) or COVID-19, and declared this infection as a pandemic on the 11 th of March, 2020. The first case of COVID-19 infection in India was reported on late January, 2020, and since then the numbers of confirmed cases have been increasing; thus the government had announced total lockdown of all activities. Most people infected with the COVID-19 virus experience mild to moderate respiratory illness, and recover without the need for special treatments. The elderly people and those with medical problems such as; cardiovascular disease, diabetes, chronic respiratory disease and cancer; are more likely to develop severe illness. Globally, corona virus cases rose to more than 500,000 for the first time on the 27 th of October, 2020. Within two weeks and since 30 th of October, 2020, COVID-19 cases had risen by almost 25 %, and about 400,000 daily cases were reported worldwide. The United States (US) was leading the global corona virus crisis with 8.9 million recorded infections and nearly 228,000 deaths worldwide. Asia had surpassed 10 million infections of the new corona virus on the 31 of October, 2020, and India reported an average of 48,000 cases daily with a total of 8 million cases. The aim of this review was to explore the epidemiological prevalence of COVID-19 in India along with age and gender stratified prevalence of this viral infection.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19在印度的流行病学情况
2019年12月下旬,中国湖北省武汉市暴发了新型冠状病毒感染,导致病因不明的急性呼吸综合征。世界卫生组织(世卫组织)将这种病毒病原体命名为严重急性呼吸综合征冠状病毒-2 (SARS-CoV2)或COVID-19,并于2020年3月11日宣布这种感染为大流行。印度于2020年1月下旬报告了第一例COVID-19感染病例,此后确诊病例数一直在增加;因此,政府宣布全面封锁所有活动。大多数感染COVID-19病毒的人会出现轻至中度呼吸道疾病,无需特殊治疗即可康复。老年人和有医疗问题的人,如;心血管疾病、糖尿病、慢性呼吸系统疾病和癌症;更有可能患上严重的疾病。2020年10月27日,全球冠状病毒病例首次超过50万例。自2020年10月30日以来,两周内COVID-19病例增加了近25%,全球每天报告的病例约为40万例。美国在全球冠状病毒危机中处于领先地位,全球有890万人感染,近22.8万人死亡。截至2020年10月31日,亚洲新冠病毒感染人数已超过1000万,印度平均每天报告4.8万例,总病例达800万例。本综述的目的是探讨COVID-19在印度的流行病学情况以及这种病毒感染的年龄和性别分层流行情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
16
审稿时长
4 weeks
期刊最新文献
Use of rpoB gene phylogenetic marker-based distinction of abiotic stress tolerant and plant-growth promoting Bacillus paralicheniformis isolates from their closely related Bacillus licheniformis From gut to brain: Deciphering the impact of gut microbiota on neurological health Association of multiple mutations in NS5A and NS5B genes and resistance to direct-acting antivirals in chronically infected Egyptian patients with Hepatitis C virus Genotype 4a Evaluation of the antioxidant and antimicrobial activities of the spent coffee extracts and their applications as natural food preservatives of chicken fillets Evaluation of the antioxidant and antimicrobial activities of the spent coffee extracts and their applications as natural food preservatives of chicken fillets
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1